483
Merck Sharp & Dohme LLCFDA 483 - Merck Sharp & Dohme LLC - November 19, 2015
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Merck Sharp & Dohme in Rahway, NJ, was cited for significant deficiencies in its conduct and oversight of clinical investigations, specifically Protocol No. P04103. The inspection revealed failures in reporting critical safety and effectiveness data, ensuring adherence to investigational plans, and proper study monitoring. These issues indicate a lack of robust controls over clinical trial data integrity and regulatory reporting.
Open in Dashboard
ID · 0aff043d-e9b8-420c-b9e3-04ea44273bb9